{"id":522311,"date":"2021-08-03T13:39:08","date_gmt":"2021-08-03T17:39:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/"},"modified":"2021-08-03T13:39:08","modified_gmt":"2021-08-03T17:39:08","slug":"shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/","title":{"rendered":"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">MILWAUKEE<\/span>, <span class=\"xn-chron\">Aug. 3, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0Ademi LLP is investigating Translate Bio (NASDAQ: TBIO) for possible breaches of fiduciary duty and other violations of law in its transaction with Sanofi. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1580107\/Ademi_LLP_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1580107\/Ademi_LLP_Logo.jpg\" title=\"AdemiLogo (PRNewsfoto\/Ademi LLP)\" alt=\"AdemiLogo (PRNewsfoto\/Ademi LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Click here to learn how to join the action: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3247658-1&amp;h=2138408895&amp;u=https%3A%2F%2Fwww.ademilaw.com%2Fcase%2Ftranslate-bio-inc&amp;a=https%3A%2F%2Fwww.ademilaw.com%2Fcase%2Ftranslate-bio-inc\" rel=\"nofollow noopener\">https:\/\/www.ademilaw.com\/case\/translate-bio-inc<\/a> or call <span class=\"xn-person\">Guri Ademi<\/span> toll-free at 866-264-3995. There is no cost or obligation to you. <\/p>\n<p>Ademi LLP alleges\u00a0Translate Bio&#8217;s financial outlook and prospects are excellent and yet Translate Bio shareholders will receive only <span class=\"xn-money\">$38<\/span> per share in a cash tender offer. The merger agreement unreasonably limits competing bids for Translate Bio\u00a0by prohibiting solicitation of further bids, and imposing a penalty of <span class=\"xn-money\">$96 million<\/span> if Translate Bio\u00a0accepts a superior bid. Translate Bio\u00a0insiders will receive millions of dollars as part of change of control arrangements. We are investigating the conduct of Translate Bio&#8217;s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Translate Bio. <\/p>\n<p>If you own Translate Bio\u00a0common stock and wish to obtain additional information, please contact <span class=\"xn-person\">Guri Ademi<\/span> either at <a target=\"_blank\" href=\"mailto:gademi@ademilaw.com\" rel=\"nofollow noopener\">gademi@ademilaw.com<\/a>\u00a0or toll-free: 866-264-3995, or <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3247658-1&amp;h=2138408895&amp;u=https%3A%2F%2Fwww.ademilaw.com%2Fcase%2Ftranslate-bio-inc&amp;a=https%3A%2F%2Fwww.ademilaw.com%2Fcase%2Ftranslate-bio-inc\" rel=\"nofollow noopener\">https:\/\/www.ademilaw.com\/case\/translate-bio-inc<\/a>.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0<\/p>\n<p>We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. <\/p>\n<p>\n        <b>Contacts<\/b>\n      <\/p>\n<p>Ademi LLP<br \/><span class=\"xn-person\">Guri Ademi<\/span><br \/>Toll Free: (866) 264-3995<br \/>Fax: (414) 482-8001<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG63113&amp;sd=2021-08-03\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi-301347182.html\">https:\/\/www.prnewswire.com\/news-releases\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi-301347182.html<\/a><\/p>\n<p>SOURCE  Ademi LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CG63113&amp;Transmission_Id=202108031336PR_NEWS_USPR_____CG63113&amp;DateId=20210803\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire MILWAUKEE, Aug. 3, 2021 \/PRNewswire\/ &#8212;\u00a0Ademi LLP is investigating Translate Bio (NASDAQ: TBIO) for possible breaches of fiduciary duty and other violations of law in its transaction with Sanofi. Click here to learn how to join the action: https:\/\/www.ademilaw.com\/case\/translate-bio-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. Ademi LLP alleges\u00a0Translate Bio&#8217;s financial outlook and prospects are excellent and yet Translate Bio shareholders will receive only $38 per share in a cash tender offer. The merger agreement unreasonably limits competing bids for Translate Bio\u00a0by prohibiting solicitation of further bids, and imposing a penalty of $96 million if Translate Bio\u00a0accepts a superior bid. Translate Bio\u00a0insiders will receive millions of dollars as part of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-522311","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MILWAUKEE, Aug. 3, 2021 \/PRNewswire\/ &#8212;\u00a0Ademi LLP is investigating Translate Bio (NASDAQ: TBIO) for possible breaches of fiduciary duty and other violations of law in its transaction with Sanofi. Click here to learn how to join the action: https:\/\/www.ademilaw.com\/case\/translate-bio-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. Ademi LLP alleges\u00a0Translate Bio&#8217;s financial outlook and prospects are excellent and yet Translate Bio shareholders will receive only $38 per share in a cash tender offer. The merger agreement unreasonably limits competing bids for Translate Bio\u00a0by prohibiting solicitation of further bids, and imposing a penalty of $96 million if Translate Bio\u00a0accepts a superior bid. Translate Bio\u00a0insiders will receive millions of dollars as part of &hellip; Continue reading &quot;Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-03T17:39:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1580107\/Ademi_LLP_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi\",\"datePublished\":\"2021-08-03T17:39:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/\"},\"wordCount\":276,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1580107\\\/Ademi_LLP_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/\",\"name\":\"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1580107\\\/Ademi_LLP_Logo.jpg\",\"datePublished\":\"2021-08-03T17:39:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1580107\\\/Ademi_LLP_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1580107\\\/Ademi_LLP_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/","og_locale":"en_US","og_type":"article","og_title":"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi - Market Newsdesk","og_description":"PR Newswire MILWAUKEE, Aug. 3, 2021 \/PRNewswire\/ &#8212;\u00a0Ademi LLP is investigating Translate Bio (NASDAQ: TBIO) for possible breaches of fiduciary duty and other violations of law in its transaction with Sanofi. Click here to learn how to join the action: https:\/\/www.ademilaw.com\/case\/translate-bio-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. Ademi LLP alleges\u00a0Translate Bio&#8217;s financial outlook and prospects are excellent and yet Translate Bio shareholders will receive only $38 per share in a cash tender offer. The merger agreement unreasonably limits competing bids for Translate Bio\u00a0by prohibiting solicitation of further bids, and imposing a penalty of $96 million if Translate Bio\u00a0accepts a superior bid. Translate Bio\u00a0insiders will receive millions of dollars as part of &hellip; Continue reading \"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-03T17:39:08+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1580107\/Ademi_LLP_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi","datePublished":"2021-08-03T17:39:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/"},"wordCount":276,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1580107\/Ademi_LLP_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/","name":"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1580107\/Ademi_LLP_Logo.jpg","datePublished":"2021-08-03T17:39:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1580107\/Ademi_LLP_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1580107\/Ademi_LLP_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-ademi-llp-investigates-whether-translate-bio-inc-has-obtained-a-fair-price-in-its-transaction-with-sanofi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shareholder Alert: Ademi LLP investigates whether Translate Bio, Inc. has obtained a Fair Price in its transaction with Sanofi"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=522311"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522311\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=522311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=522311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=522311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}